Opko Health, Inc.
OPK
$1.28
-$0.02-1.54%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 689.41M | 713.14M | 711.41M | 716.37M | 799.60M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 689.41M | 713.14M | 711.41M | 716.37M | 799.60M |
| Cost of Revenue | 584.47M | 599.85M | 627.03M | 615.11M | 617.60M |
| Gross Profit | 104.94M | 113.30M | 84.38M | 101.26M | 182.01M |
| SG&A Expenses | 293.14M | 304.22M | 310.07M | 284.11M | 295.08M |
| Depreciation & Amortization | 81.06M | 82.63M | 83.78M | 84.88M | 86.00M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 958.66M | 986.70M | 1.02B | 984.10M | 998.68M |
| Operating Income | -269.25M | -273.56M | -309.48M | -267.73M | -199.07M |
| Income Before Tax | -578.00K | -10.38M | -117.86M | -244.67M | -250.58M |
| Income Tax Expenses | 38.42M | 42.84M | 15.88M | -1.57M | 1.85M |
| Earnings from Continuing Operations | -39.00 | -53.22 | -133.73 | -243.10 | -252.43 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -39.00M | -53.22M | -133.73M | -243.10M | -252.43M |
| EBIT | -269.25M | -273.56M | -309.48M | -267.73M | -199.07M |
| EBITDA | -173.41M | -175.38M | -209.36M | -165.46M | -94.40M |
| EPS Basic | -0.06 | -0.07 | -0.18 | -0.33 | -0.34 |
| Normalized Basic EPS | -0.03 | -0.04 | -0.25 | -0.20 | -0.21 |
| EPS Diluted | -0.07 | -0.08 | -0.19 | -0.33 | -0.35 |
| Normalized Diluted EPS | -0.04 | -0.05 | -0.22 | -0.20 | -0.21 |
| Average Basic Shares Outstanding | 2.74B | 2.78B | 2.85B | 2.91B | 2.96B |
| Average Diluted Shares Outstanding | 3.32B | 3.35B | 3.15B | 2.91B | 2.96B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |